Since the UK National Screening Committee (UK NSC) recommended targeted prostate screening for men aged 45 to 61 who carry a BRCA2 gene change and have a family history of specific cancers in May 2026, there has been a rapid increase in the number of Hereditary Cancer tests requested. Learn why…